Pure Eyes Skin Booster 2%

Pure Eyes Skin Booster 2%

Pure

Injectable aesthetic treatment
  • Distributed in the UK by AestheticsRx Pharma, a professional aesthetics pharmacy and supplier, and by other regulated wholesale partners through platforms such as Faces Consent.
  • Marketed as a professional PN skin booster for under Eye use; regulatory classification may vary by region (cosmetic injectable or medical device/medicinal product depending on jurisdiction).
  • Intended strictly for professional use in compliance with local aesthetic practice standards, prescription requirements and pharmacovigilance obligations.
Under-eye polynucleotide (PN) skin booster

Description

Pure Eyes Skin Booster 2% is an advanced injectable treatment specifically developed for the delicate under-eye area. Listed as a 2% skin booster by AestheticsRx Pharma, it is part of the Pure Eyes Polynucleotide (PN) booster family, which combines sodium polynucleotide and hyaluronic acid to improve hydration, collagen regeneration and overall skin quality. Designed to deeply hydrate, smooth and rejuvenate tired-looking eyes, this skin booster improves elasticity and texture, helping to reduce fine lines, crepiness, puffiness and early hollowing while restoring a fresher, more radiant look. Unlike traditional volumising fillers, Pure Eyes focuses on skin quality rather than bulk volume, making it ideal for patients seeking natural under-eye revitalisation. Treatments are delivered using microinjections by trained professionals, ensuring precise placement and patient comfort.

Bnefits

  • Deeply hydrates and smooths the under-eye area, helping to reduce fine lines and crepiness.
  • Improves skin elasticity and texture, resulting in a brighter, more refreshed eye contour.
  • Rejuvenates tired, dull-looking eyes for a more rested and youthful appearance.
  • Polynucleotide (PN) technology supports collagen regeneration and skin repair.
  • Formulated to enhance skin quality rather than create excessive volume, reducing the risk of an overfilled look.
  • Targets common under-eye concerns such as early hollowing, puffiness and signs of fatigue.
  • Designed for the delicate periorbital area with a focus on safety and comfort when used by trained professionals.
  • Can provide long-lasting skin hydration and quality improvements with a course of treatments.

Indications

  • Under-eye fine lines and wrinkles.
  • Crepey, dry or thinning skin around the eyes.
  • Early tear trough hollowing and loss of under-eye volume related to skin quality changes.
  • Dark circles and signs of fatigue or dullness in the periorbital region.
  • Patients seeking non-surgical under-eye revitalisation focused on skin quality rather than bulk filling.

Composition

  • Sodium polynucleotide (PN) – polynucleotide booster active designed to improve hydration, collagen regeneration and tissue repair.
  • Hyaluronic acid – provides additional hydration and supports a smoother, more supple skin surface.
  • Other excipients – buffer and stabilising components to maintain product sterility, viscosity and comfort (exact excipient list not fully disclosed in public sources).

Formulation

  • Injectable polynucleotide (PN) skin booster solution for under-eye use.
  • Combines sodium polynucleotide and hyaluronic acid in a 2% PN formulation (marketed as Pure Eyes 2%).
  • Sterile, single-use pre-filled syringe presentation intended for professional injection using microdroplet techniques.
  • Designed to be administered by trained practitioners via shallow microinjections in the periorbital area.

Packaging

  • Typically supplied as 1 x 1.1 ml pre-filled syringe per box (no needles included), as indicated for Pure Eyes PN boosters.
  • Syringe packaged in a protective blister with product label, batch number and expiry date.
  • Outer carton labelled with product name (Pure Eyes 2% Skin Booster), volume, and distributor/importer information.
  • Some wholesalers also offer multi-box bundles (e.g., 5-box packages) for clinic stock.

Usage

  • For professional use only; Pure Eyes Skin Booster must be administered by an appropriately trained medical or aesthetic practitioner.
  • Prior to treatment, assess the patient’s medical history, indications and suitability for under-eye PN skin booster therapy.
  • Cleanse and disinfect the periorbital area thoroughly in line with clinic infection-control protocols.
  • Using a fine needle (e.g., 30–32G) or other suitable device, perform a series of microinjections in the superficial to mid-dermis of the under-eye and tear trough region, avoiding intravascular injection and respecting anatomical safety zones.
  • Distribute small aliquots of product evenly across the treatment area using microdroplet or linear threading techniques, according to practitioner preference and patient anatomy.
  • Treatment protocols may involve a course of sessions (commonly 2–3 treatments spaced several weeks apart), followed by maintenance sessions as needed; the exact schedule should be tailored to individual patient needs.
  • After treatment, advise patients to avoid touching or applying makeup to the treated area for the first 12–24 hours, to avoid vigorous rubbing or massage, and to use broad-spectrum sunscreen as part of ongoing skin care.
  • Instruct patients to report any unexpected or severe side effects such as intense pain, sudden vision changes, severe swelling or signs of infection immediately.

Contraindications

  • Known allergy or hypersensitivity to polynucleotides, hyaluronic acid or any component of the formulation.
  • Active skin infections, inflammation or dermatologic conditions (e.g., dermatitis, eczema) in the intended treatment area.
  • Active herpes simplex lesions near the treatment area.
  • History of severe allergic reactions or anaphylaxis to injectable aesthetic products.
  • Bleeding disorders or current use of anticoagulant therapy that may increase risk of bruising or bleeding, unless carefully evaluated by a medical professional.
  • Pregnancy or breastfeeding, due to limited safety data for this patient group.
  • Use in patients with severe systemic disease or uncontrolled autoimmune conditions should be carefully assessed and may be contraindicated.
  • Not for self-administration or use outside of professional clinical environments.

Adverse Effects

  • Transient redness, swelling and tenderness at injection sites.
  • Mild to moderate bruising in the under-eye area, typically resolving in a few days.
  • Temporary puffiness or oedema, especially in individuals with pre-existing under-eye fluid retention.
  • Rare hypersensitivity or allergic reactions to product components.
  • As with any injectable treatment, there is a small risk of infection, vascular compromise or other complications if not performed with appropriate technique and aseptic measures.

Storage Conditions

  • Store in a cool, dry place away from direct sunlight and sources of heat.
  • Do not freeze; protect from extreme temperatures that may compromise product integrity.
  • Keep the pre-filled syringe in its original blister and outer carton until ready for use.
  • Do not use after the expiry date printed on the packaging, and discard any unused portion of an opened syringe according to clinical waste protocols.

Duration

Individual treatment sessions typically take around 20\u201330 minutes including consultation and preparation. A full treatment course often consists of 2\u20133 sessions spaced a few weeks apart, with maintenance treatments thereafter depending on clinical response and patient goals.

Onset

Early improvements in under-eye hydration and smoothness are usually noticeable within days after treatment. More significant changes in skin quality, elasticity and fine lines generally develop over several weeks, especially after completing a course of treatments.

Browse more Injectable aesthetic treatment

Top Treatments

Top Cities in the UK